Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Accelerate Promotion and Dissemination of Appropriate Atopic Dermatitis Diagnosis, Treatment, and Management Guidance
Release Date:
Partner: Japanese Dermatological Association
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Japan
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
Release Date:
Review Process: Pfizer Internal
Research Rare Disease All
Pediatric Endocrinology Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Growth Hormone Research- United States
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Treatment of acute SARS-CoV-2 infection and management of post-COVID conditions in outpatient settings (European countries)
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Topical Hemostasis in Hospital Outpatient and Ambulatory Surgery
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic Embolism
Release Date:
Review Process: Pfizer Internal
Quality Improvement Internal Medicine Japan
Atopic Dermatitis and Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada
Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care Professionals
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for Proposals
Release Date:
Partner: Bladder Cancer Canada, EMD Serono
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada